Healthcare Services

Human Chorionic Gonadotropin Market Outlook (2026–2030): Trends and Drivers

April 22, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Human Chorionic Gonadotropin Market From 2026 To 2030?

The human chorionic gonadotropin market size has experienced robust growth in recent years. This market is anticipated to expand from $1.02 billion in 2025 to $1.11 billion in 2026, registering a compound annual growth rate (CAGR) of 8.3%. The historic period’s growth can be attributed to the increasing prevalence of infertility, the global expansion of fertility clinics, the enduring clinical application of hCG in reproductive medicine, rising awareness regarding hormonal imbalance treatments, and the availability of natural source hCG products.

The human chorionic gonadotropin market is anticipated to experience substantial expansion in the coming years, projected to reach $1.52 billion by 2030 with a compound annual growth rate (CAGR) of 8.2%. This projected growth is driven by several factors, including the increasing need for assisted reproductive technologies, a greater uptake of recombinant hormones, an intensified focus on personalized fertility solutions, the broadening reach of online and retail pharmacy channels, and increased funding for reproductive health studies. Key developments during this period encompass the expanded application of hCG in assisted reproductive procedures, a surging requirement for hormonal treatments in managing infertility, the growing acceptance of recombinant hCG products, an broadening of hCG uses for male hormonal conditions, and an intensified emphasis on hormone formulations that are standardized and highly pure.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report

What Key Drivers Are Fueling The Growth Of The Human Chorionic Gonadotropin Market?

The human chorionic gonadotropin market is anticipated to experience growth due to the escalating rate of infertility. Infertility is characterized by the inability to achieve conception after a minimum of one year of consistent, unprotected sexual intercourse. The increase in infertility rates is observed as more individuals and couples encounter difficulties conceiving, influenced by factors such as delayed childbearing, changes in lifestyle, exposure to environmental elements, and various medical conditions. Human chorionic gonadotropin (hCG) is utilized in infertility treatments to stimulate ovulation in women and support testosterone production in men, thereby facilitating egg release and enhancing fertility outcomes. For instance, in April 2023, the World Health Organization, an intergovernmental organization based in Switzerland, reported that infertility affected approximately 17.5% of the adult population globally, equating to roughly one in every six people, underscoring the urgent necessity for improved access to affordable, high-quality fertility care for those in need. Consequently, the rising incidence of infertility is a key factor driving the expansion of the human chorionic gonadotropin market. Global Human Chorionic Gonadotropin Market Driver: Rise In Aging Population Fueling The Growth Of The Market Due To Increasing Need For Hormone Support Among Older Adults

The human chorionic gonadotropin market is projected to grow owing to the increasing aging population. An aging population describes a demographic shift where there is a growing proportion of older individuals within a society, a trend driven by extended life expectancy and declining birth rates. This rise in the aging demographic is primarily a result of advancements in healthcare that have prolonged human lifespans. Human chorionic gonadotropin (hCG) is employed by the aging population to assist in maintaining hormone balance and supporting testosterone levels. For example, the Population Reference Bureau, a US-based non-profit organization, stated in January 2024 that the number of Americans aged 65 and older is expected to increase from 58 million in 2022 to 82 million by 2050, marking a substantial 47% rise. As a result, this age group’s share of the total U.S. population will grow from 17% to 23% during the same period. Therefore, the expansion of the aging population is a significant factor propelling the growth of the human chorionic gonadotropin market.

How Is The Human Chorionic Gonadotropin Market Categorized Across Its Segment Groups?

The human chorionic gonadotropin market covered in this report is segmented –

1) By Technology: Natural Source Extraction, Recombinant Technology

2) By Therapeutic Area: Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Fertility Clinics, Research Institutions, Other End Users

Subsegments:

1) By Natural Source Extraction: Extraction From Pregnant Women’s Urine, Purified Urinary hCG (u-hCG) Formulations

2) By Recombinant Technology: Recombinant Hcg, Recombinant Hcg For Therapeutic Use, Recombinant Hcg For Diagnostic Applications

Which Firms Are Influencing Competition In The Human Chorionic Gonadotropin Market?

Major companies operating in the human chorionic gonadotropin market are Ferring Pharmaceuticals, Merck KGaA, Organon, IBSA Institut Biochimique, Teva Pharmaceutical Industries, Sandoz, Sun Pharmaceutical Industries, Cipla, Zydus Lifesciences, Lupin, Intas Pharmaceuticals, Hikma Pharmaceuticals, Aspen Pharmacare, Menarini Group, Bharat Serums and Vaccines, Serum Institute of India, LG Chem Life Sciences, Dong-A ST, Livzon Pharmaceutical Group, SciGen

Get The Full Human Chorionic Gonadotropin Market Report:

https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report

Which Region Dominates The Human Chorionic Gonadotropin Market By Market Share?

North America was the largest region in the human chorionic gonadotropin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Human Chorionic Gonadotropin Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report

Browse Through More Reports Similar to the Global Human Chorionic Gonadotropin Market 2026, By The Business Research Company

Hormone Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Male Hypogonadism Market Report 2026

https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

Gonadotropin Releasing Hormone Gnrh Agonist Market Report 2026

https://www.thebusinessresearchcompany.com/report/gonadotropin-releasing-hormone-gnrh-agonist-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795